TLPH|EPS -$0.06|Net Loss $3.8M
Talphera Inc (TLPH) reported Q4 2025 GAAP earnings of -$0.06 per share.
Talphera Inc is a Drug Manufacturers – Specialty & Generic company. The company posted a net loss of $3.8M for the quarter.
Cash operating expenses, or selling, general and administrative, and research and development expenses, excluding stock-based compensation, are expected to be in the range of $17 million to $18 million in fiscal year 2026.
This article was generated with the assistance of AI technology and reviewed for accuracy. AlphaStreet may receive compensation from companies mentioned in this article. This content is for informational purposes only and should not be considered investment advice.